| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Albuterol | FAERS: 2 | US FAERS | |
| 2 | Breo Ellipta | FAERS: 2 | US FAERS | |
| 3 | Fluticasone | FAERS: 2 | US FAERS | |
| 4 | regorafenib | FAERS: 2 | US FAERS | |
| 5 | Dimethyl Fumarate | FAERS: 1 | US FAERS | |
| 6 | Dymista | FAERS: 1 | US FAERS | |
| 7 | Fluticasone-Salmeterol Drug Combination | FAERS: 1 | US FAERS | |
| 8 | Glatiramer Acetate | FAERS: 1 | US FAERS | |
| 9 | Lansoprazole | FAERS: 1 | US FAERS | |
| 10 | Mometasone Furoate | FAERS: 1 | US FAERS | |
| 11 | Vemurafenib | FAERS: 1 | US FAERS | |
| 12 | treprostinil | FAERS: 1 | US FAERS | |
| 13 | Albuterol | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.